Castleview Partners, LLC Moderna, Inc. Transaction History

Castleview Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $1.25 Million - $2.06 Million	-10,628 Reduced 99.48%	56 $7,000
Q2 2022 Aug 17, 2022	BUY	$117.13 - $176.59 $665,884 - $1 Million	5,685 Added 113.72%	10,684 $1.53 Million
Q2 2022 Aug 16, 2022	BUY	$117.13 - $176.59 $581,433 - $876,592	4,964 Added 14182.86%	4,999 $714,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $4,426 - $8,226	35 New	35 $6,000
Q4 2021 Feb 17, 2022	SELL	$225.82 - $368.51 $7,903 - $12,897	-35 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$129.91 - $234.98 $4,546 - $8,224	35 New	35 $8,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.